The effects of peptide histidine isoleucine on antral gastrin and somatostatin

M. Michael Wolfe, Rin Chang, Mark E Mailliard, Pratima S. Karnik

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present studies were directed to determine whether peptide histidine isoleucine (PHI) affects expression of the gastrin and somatostatin genes and whether such effects may be functionally linked. In separate experiments, the effects of PHI on medium gastrin and somatostatin concentrations, the incorporation of 35S-labelled amino acids into newly synthesized gastrin and somatostatin, and steady state gastrin and somatostatin mRNA were determined. PHI inhibited basal expression of the gastrin gene at all levels examined, while no significant effect on basal somatostatin gene expression could be detected. PHI also decreased carbachol-stimulated antral gastrin release and simultaneously increased somatostatin release. However, in contrast to its structural analogues, secretin and gastric inhibitory peptide, the immunoneutralization of endogenous somatostatin by the administration of specific antibodies did not affect significantly the capacity of PHI to inhibit gastrin release into the culture medium stimulated by carbachol. The results of these studies indicate that PHI exerts a physiological inhibitory effect on antral gastrin cells and that this inhibition may occur at several steps along the biosynthetic pathway. In addition, unlike its structural analogues, PHI inhibition of carbachol-stimulated gastrin release is not functionally linked to its stimulatory effects on somatostatin release.

Original languageEnglish (US)
Pages (from-to)89-97
Number of pages9
JournalMolecular and Cellular Endocrinology
Volume84
Issue number1-2
DOIs
StatePublished - Jan 1 1992

Fingerprint

Peptide PHI
Gastrins
Somatostatin
Carbachol
Genes
Gene Expression
Gastrin-Secreting Cells
Secretin
Antral
Biosynthetic Pathways
Culture Media
Gene expression
Stomach
Amino Acids
Messenger RNA
Peptides

Keywords

  • Gene expression
  • Messenger RNA
  • Peptide biosynthesis
  • Tissue culture
  • Vasoactive intestinal peptide

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Cite this

The effects of peptide histidine isoleucine on antral gastrin and somatostatin. / Wolfe, M. Michael; Chang, Rin; Mailliard, Mark E; Karnik, Pratima S.

In: Molecular and Cellular Endocrinology, Vol. 84, No. 1-2, 01.01.1992, p. 89-97.

Research output: Contribution to journalArticle

Wolfe, M. Michael ; Chang, Rin ; Mailliard, Mark E ; Karnik, Pratima S. / The effects of peptide histidine isoleucine on antral gastrin and somatostatin. In: Molecular and Cellular Endocrinology. 1992 ; Vol. 84, No. 1-2. pp. 89-97.
@article{654c7dc79f734198aa789a1a9242afd0,
title = "The effects of peptide histidine isoleucine on antral gastrin and somatostatin",
abstract = "The present studies were directed to determine whether peptide histidine isoleucine (PHI) affects expression of the gastrin and somatostatin genes and whether such effects may be functionally linked. In separate experiments, the effects of PHI on medium gastrin and somatostatin concentrations, the incorporation of 35S-labelled amino acids into newly synthesized gastrin and somatostatin, and steady state gastrin and somatostatin mRNA were determined. PHI inhibited basal expression of the gastrin gene at all levels examined, while no significant effect on basal somatostatin gene expression could be detected. PHI also decreased carbachol-stimulated antral gastrin release and simultaneously increased somatostatin release. However, in contrast to its structural analogues, secretin and gastric inhibitory peptide, the immunoneutralization of endogenous somatostatin by the administration of specific antibodies did not affect significantly the capacity of PHI to inhibit gastrin release into the culture medium stimulated by carbachol. The results of these studies indicate that PHI exerts a physiological inhibitory effect on antral gastrin cells and that this inhibition may occur at several steps along the biosynthetic pathway. In addition, unlike its structural analogues, PHI inhibition of carbachol-stimulated gastrin release is not functionally linked to its stimulatory effects on somatostatin release.",
keywords = "Gene expression, Messenger RNA, Peptide biosynthesis, Tissue culture, Vasoactive intestinal peptide",
author = "Wolfe, {M. Michael} and Rin Chang and Mailliard, {Mark E} and Karnik, {Pratima S.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0303-7207(92)90075-H",
language = "English (US)",
volume = "84",
pages = "89--97",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - The effects of peptide histidine isoleucine on antral gastrin and somatostatin

AU - Wolfe, M. Michael

AU - Chang, Rin

AU - Mailliard, Mark E

AU - Karnik, Pratima S.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The present studies were directed to determine whether peptide histidine isoleucine (PHI) affects expression of the gastrin and somatostatin genes and whether such effects may be functionally linked. In separate experiments, the effects of PHI on medium gastrin and somatostatin concentrations, the incorporation of 35S-labelled amino acids into newly synthesized gastrin and somatostatin, and steady state gastrin and somatostatin mRNA were determined. PHI inhibited basal expression of the gastrin gene at all levels examined, while no significant effect on basal somatostatin gene expression could be detected. PHI also decreased carbachol-stimulated antral gastrin release and simultaneously increased somatostatin release. However, in contrast to its structural analogues, secretin and gastric inhibitory peptide, the immunoneutralization of endogenous somatostatin by the administration of specific antibodies did not affect significantly the capacity of PHI to inhibit gastrin release into the culture medium stimulated by carbachol. The results of these studies indicate that PHI exerts a physiological inhibitory effect on antral gastrin cells and that this inhibition may occur at several steps along the biosynthetic pathway. In addition, unlike its structural analogues, PHI inhibition of carbachol-stimulated gastrin release is not functionally linked to its stimulatory effects on somatostatin release.

AB - The present studies were directed to determine whether peptide histidine isoleucine (PHI) affects expression of the gastrin and somatostatin genes and whether such effects may be functionally linked. In separate experiments, the effects of PHI on medium gastrin and somatostatin concentrations, the incorporation of 35S-labelled amino acids into newly synthesized gastrin and somatostatin, and steady state gastrin and somatostatin mRNA were determined. PHI inhibited basal expression of the gastrin gene at all levels examined, while no significant effect on basal somatostatin gene expression could be detected. PHI also decreased carbachol-stimulated antral gastrin release and simultaneously increased somatostatin release. However, in contrast to its structural analogues, secretin and gastric inhibitory peptide, the immunoneutralization of endogenous somatostatin by the administration of specific antibodies did not affect significantly the capacity of PHI to inhibit gastrin release into the culture medium stimulated by carbachol. The results of these studies indicate that PHI exerts a physiological inhibitory effect on antral gastrin cells and that this inhibition may occur at several steps along the biosynthetic pathway. In addition, unlike its structural analogues, PHI inhibition of carbachol-stimulated gastrin release is not functionally linked to its stimulatory effects on somatostatin release.

KW - Gene expression

KW - Messenger RNA

KW - Peptide biosynthesis

KW - Tissue culture

KW - Vasoactive intestinal peptide

UR - http://www.scopus.com/inward/record.url?scp=0026601057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026601057&partnerID=8YFLogxK

U2 - 10.1016/0303-7207(92)90075-H

DO - 10.1016/0303-7207(92)90075-H

M3 - Article

VL - 84

SP - 89

EP - 97

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -